Provincial torchbearers, there are two spikes!
Release time:
2022-10-08
News from our newspaper # February 29 , the torch relay of the 17th Zhejiang Games was held in Jinhua city. Zheng Kunwu, production manager of Jianfeng Pharmaceutical Company, and Guo Xuhua, quality manager of Zhejiang Erying Pharmaceutical Co., Ltd., as torchbearers of Jinhua Development Zone, took part in the torch relay of and respectively in Jinhua city, it shows the high-spirited and upward spirit of the peak people, cheering and adding luster to the Provincial Games.
There are about 1.5 athletes participating in this provincial games, which is the largest provincial games in the history of Zhejiang Province. A total of 363 torchbearers were selected in the province, of which 60 were in Jinhua Development Zone.
Zheng Kunwu entered Jianfeng Pharmaceutical after graduating from university in , 2000 . He has been committed to the production of drugs and equipment innovation, obtained a number of invention patents and utility model patents, and made outstanding contributions to the reduction of costs and efficiency of enterprises and the technological progress of the industry. He has won many honors such as outstanding employees, outstanding scientific and technological workers, outstanding Communist Party members and outstanding management workers of the company, he was rated as an outstanding communist party member of Jinhua SASAC and won the second prize of scientific and technological progress in Jinhua. Guo Xuhua is the training target of Jinhua 321 talents. He led the team to create a drug quality management system, obtained Jinhua's first B certificate "Drug Production License", and won the honorary titles of Jinhua's outstanding medical scientific and technological workers, outstanding company cadres and outstanding community communists.
to become a torchbearer of the provincial games, to go through the unit recommendation, material reporting, organization screening, physical examination and other procedures, after being selected, but also to participate in relevant training and exercises. Zheng Kunwu said that participating in the torch relay is a sacred and glorious task, and it also proves the recognition of Jianfeng Pharmaceutical by the government and all sectors of society. Guo Xuhua said that he was very excited to learn that he was selected as a torchbearer. It is an experience he has never had before to participate in the torch relay at his doorstep. It is also the supreme honor and mission. It will be the most beautiful memory in his life.
In order to fully display the image of the peak and the spirit of the peak people during the torch relay, Zheng Kunwu and Guo Xuhua used a lot of brains, and their colleagues also helped to put forward many ideas, such as making the shape of "sharp" and climbing the mountain during the torch handover. For this reason, the two also explained, communicated and practiced with their previous torchbearers many times, and finally determined the double climbing and shouted out the "determination to rise to the top" in the spirit of the peak and the theme of the Provincial Games. The handover of "Rise of Central Zhejiang" was successfully completed in the final torch relay.
(ReporterNi Yingzhen Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31